电话:
+86 (0512) 65829739
传真:
+86 (010) 6788 5057
电子邮件:
orders@antibodies-online.cn

Mortality Factor 4 (MORF4) Peptide

MORF4 适用: 哺乳动物 宿主: 合成 BP, WB, IHC
产品编号 ABIN940199
发货至: 中国

Quick Overview for Mortality Factor 4 (MORF4) Peptide (ABIN940199)

抗原

MORF4 (Mortality Factor 4 (MORF4))

宿主

哺乳动物

资源

  • 1
合成

应用范围

Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
  • 蛋白类型

    Synthetic

    序列

    LAYTPLNEKS LALLLNYLHD FLKYLAKNSA TLFSASDYEV ALPEYHRKAV

    产品特性

    A synthetic peptide for use as a blocking control in assays to test for specificity of MORF4 antibody,
    Alternative Names: MORF4 control peptide, MORF4 antibody Blocking Peptide, Anti-MORF4 Blocking Peptide, mortality factor 4 Blocking Peptide, CSR Blocking Peptide, CSRB Blocking Peptide, SEN Blocking Peptide, SEN1 Blocking Peptide, MORF4, MORF-4, MORF 4, MORF-4 Blocking Peptide, MORF 4 Blocking Peptide

    纯化方法

    The antibody is affinity-purified from rabbit antiserum by affinity chromatography using epitope-specific phosphopeptide. The antibody against non-phosphopeptide is removed by chromatogramphy using non-phosphopeptide corresponding to the phosphorylation site.
  • 应用备注

    Optimal conditions should be determined by the investigator

    限制

    仅限研究用
  • 状态

    Lyophilized

    溶解方式

    Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.

    缓冲液

    PBS

    注意事项

    Avoid repeated freeze/thaw cycles.

    储存条件

    -20 °C

    储存方法

    Store at -20 °C long term.
  • 抗原

    MORF4 (Mortality Factor 4 (MORF4))

    背景

    Cellular senescence, the terminal nondividing state that normal cells enter following completion of their proliferative potential, is the dominant phenotype in hybrids of normal and immortal cells. Fusions of immortal human cell lines with each other have led to their assignment to 1 of several complementation groups. MORF4 is a gene on chromosome 4 that induces a senescent-like phenotype in cell lines assigned to complementation group B.

    分子量

    27 kDa
You are here:
Chat with us!